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Tumor necrosis factorAbstract Background: Neonatal sepsis is considered one of the major causes of morbidity and
mortality in NICUs. To avoid unnecessary treatment of non-infected neonates, emergence of mul-
tidrug resistance organisms, prolonged hospitalization and a considerable economic burden, partic-
ularly in developing countries with poorly-equipped NICUs, an early, sensitive and speciﬁc
laboratory test would be helpful to guide clinicians in neonatal units to decide whether or not to
start antibiotics.
Objective: C-reactive protein (CRP), tumor necrosis factor-a (TNF), interleukin-6 (IL-6) and
interleukin-1 (IL-1) were measured in an attempt to identify a set of tests which can conﬁrm or
refute the diagnosis of neonatal sepsis at an early stage before administration of antibiotics.
Methods: Assessment of serum levels of CRP, TNF-a, IL-6 and IL-1 was done using quantitative
enzyme immunoassay sandwich technique in 116 neonates (36 newborns with clinically suspected
sepsis, 48 newborns with culture-proven sepsis and 32 infection-free neonates).
Results: The cutoff levels for CRP at >12 mg/l had a sensitivity of 91% and speciﬁcity of 100%,
for TNF-a at>113.2 ng/ml had a sensitivity of 83%and speciﬁcity of 100%, for IL-6 at>16.8 pg/ml
had a sensitivity of 100% and speciﬁcity of 47%, and for IL-1 at>15 pg/ml had a sensitivity of 100%
and speciﬁcity of 47% for the diagnosis of infection before antibiotics.l.: +20
92 M.M. El-Sonbaty et al.Conclusion: The area under ROC curve (AUC) of TNF and CRP in the diagnosis of sepsis was supe-
rior to determinations of IL-1 and IL-6. From our data analysis and based on our ﬁnancial back-
grounds, we can conclude that abnormal of CRP levels together with immature-to-total neutrophil
ratio above 0.2 with or without elevated IL-1, IL-6 or TNF can be used as early markers of sepsis
in neonates.
 2016 The Egyptian Pediatric Association. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Neonatal sepsis is considered one of the major causes of mor-
bidity and mortality in neonatal intensive care units (NICUs),
despite major advances in the management of newborn
infants.1 Blood culture has been considered the gold standard
diagnostic test but its analysis takes too long time and lacks
sensitivity at early stages.2 It is also thought that total leuko-
cyte count (TLC), total neutrophil count, immature-to-total
neutrophil ratio (I/T), and platelet count also failed to reach
the appropriate sensitivity and speciﬁcity in this disease.3
However, rapid diagnosis is still a major challenge in the
management of neonatal sepsis especially at early stages due
to non-speciﬁc clinical signs that may be minimal and resemble
those caused by various non-infective conditions and the fact
that infection markers showed difﬁculty to be interpreted dur-
ing the early neonatal sepsis.4–6 Hence it is becoming increas-
ingly important to ﬁnd an early sensitive and speciﬁc
biochemical test to differentiate sick newborns with or without
infection, especially to minimize the empirical use of antibi-
otics, emergence of multidrug resistance organisms, prolonged
hospitalization and a considerable economic burden, particu-
larly in developing countries with poorly-equipped NICUs like
Egypt.7,8
Finding a reliable laboratory test as a marker for immediate
detection of infection with acceptable sensitivity and speciﬁcity
has always been controversial among investigators. Recently
various biochemical markers, for example C-reactive protein
(CRP), tumor necrosis factor (TNF-a) and interleukins have
been evaluated as potential indicators for early identiﬁcation
of septic infants.7
The aim of this study was to evaluate CRP, TNF-a,
interleukin-6 (IL-6) and interleukin-1 (IL-1) as potential early
diagnostic markers of neonatal infection. We also aimed to
determine the speciﬁcity and sensitivity of interleukins in early
detection of neonatal infection, and suggest cutoff values for
studied interleukins in order to detect infections.
Subjects and methods
Subjects
All neonates admitted to the NICU of Cairo University during
the period from June 2014 to December 2014, were enrolled in
this study. Of 181 eligible infants, 116 were enrolled in the
study; 65 infants were excluded because insufﬁcient blood sam-
pling, incomplete documentation, history of perinatal asphyx-
ia, inter-current illnesses, known congenital anomalies,
chromosomal abnormalities or inborn errors of metabolism,
conﬁrmed intrauterine viral infection and who were already
receiving parenteral antibiotic at the time of study.The study protocol was approved by the Ethical Committee
of Cairo University & the Ethical Committee of National
Research Center, Cairo, Egypt. A written consent was
obtained from parents of neonates included in the study.
Full medical history was obtained from the parents then all
neonates are subjected to full clinical examination, especially
for the clinical signs of infections (poor peripheral perfusion,
capillary reﬁlling time >3 s, hypotension, hypothermia or
hyperthermia, poor neonatal reﬂexes, hypotonia, abdominal
distension, tachypnea, increased or decreased heart rate).
Routine complete blood count, differential TLC, blood
cultures and other relevant cultures were done for all patients
at the time of enrollment.
According to results of previous parameters, neonates
enrolled in the study were divided into three groups:
1- Culture-proven sepsis group where sepsis was conﬁrmed
by a positive blood culture or other relevant cultures
accompanied by compatible signs and symptoms.
2- Clinically suspected sepsis group that was deﬁned as
clinical symptoms and/or signs suggestive of sepsis and
necessitated the start of antibiotic therapy but not con-
ﬁrmed by laboratory tests (negative culture).
3- Control group that includes all infection-free neonates,
without clinical ﬁndings or maternal risk factors for
infection, admitted for minor problems or nursed in
the neonatal ward at the same period.
Methods
Adequate venous blood samples were taken from each infant
for analysis in the ﬁrst 6 h of admission and before administra-
tion of antibiotics. Blood samples were collected into plain
evacuated blood tubes and were allowed to clot for 60 min
then centrifuged at 4000 rpm for 10 min. Hemolyzed samples
were excluded from analysis. After separation, routine analysis
and assessment of CRP were done and aliquots of serum were
frozen at 80 C for TNF-a, IL-6 and IL-1 analysis.
CRP, TNF-a, IL-6 and IL-1 were assessed using Quan-
tikine ELISA kit, R&D, Bio-Techne, Minneapolis, USA.3
Statistical analysis
Statistical calculations were done using Statistical Package for
the Social Science (SPSS Inc., Chicago, IL, USA) version 16
for Microsoft Windows. Data were statistically presented in
terms of mean, standard deviation (SD), and range, or fre-
quencies (number of cases) and percentages when appropriate.
Comparison of numerical variables between the study groups
was done using one way analysis of variance (ANOVA) test.
For comparing categorical data, Chi square test was per-
formed. Exact test was used instead when the expected
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(ROC) curve was made and area under the curve (AUC) was
calculated. The optimal cutoff was determined for the vari-
ables required. P value was considered to be signiﬁcant if less
than 0.05.
Results
– The demographic and clinical characteristics of each group
are shown in Table 1.
– The laboratory data showed that septic neonates and neo-
nates with suspected sepsis had signiﬁcantly elevated levels
of CRP, TNF-a, IL-6, IL-1 and when compared to the con-
trol group (Table 2).
– On comparing the laboratory data of septic neonates and
neonates with suspected sepsis, we found that TLC, I/T
ratio, and IL-6 were comparable between both groups
(P> 0.05). CRP and TNF were signiﬁcantly higher and
PLT and IL-1 were lower in septic group when compared
to neonates with suspected sepsis (Table 3).Table 1 Neonatal characteristics of the studied groups.





Median (range) 38 (33–40)
Birth weight (kg):
Median (range) 2.9 (1.3–3.6)
Postnatal age:
Median (range) 11.5 (2–28)
Table 2 Laboratory characteristics of the studied groups.
Variables Culture-proven sepsis group (n= 48) Sepsis su
Median Range Median
CRP (mg/l) 48 12–192 12
TNF-a (ng/ml) 153.3 105–120 107.9
IL-6 (pg/ml) 36.0 27.1–45.9 37.9
IL-1 (pg/ml) 26.0 21.4–41.7 30
Table 3 Laboratory characteristics of septic neonates and suspiciou
Variables Culture-proven sepsis group (n= 48)
Median Range
TLC (103/ccm) 9.6 1.7–28.9
I/T ratio 0.33 0.25–0.77
Platelet (103/ccm) 95.0 10–200
CRP (ng/ml) 48 12–192
IL-1 (pg/ml) 26.0 21.4–41.7
IL-6 (pg/ml) 36.0 27.1–45.9
TNF-a (ng/ml) 153.3 105–120– The sensitivity of IL-1 and IL-6 was 100% with speciﬁcity
below 50% and their AUC was signiﬁcant in diagnosing
sepsis. The speciﬁcity of TNF and CRP in the diagnosis
of sepsis and their AUC were superior to determinations
of IL-1 and IL-6 (Table 4 and Fig. 1).
Discussion
Neonatal sepsis is considered one of the major causes of mor-
bidity and mortality in NICUs. To avoid unnecessary treat-
ment of non-infected neonates, emergence of multidrug
resistance organisms, prolonged hospitalization and a consid-
erable economic burden, particularly in developing countries
with poorly-equipped NICUs, an early, sensitive and speciﬁc
laboratory test would be helpful to guide clinicians in neonatal
units to decide whether or not to start antibiotics.
This study was done for a period of six months in NICU in
Cairo University which considered the biggest unit in Egypt.
We have assessed hematological data and routine laboratorySuspicion group (n= 36) Control group (n= 32)
36 (100%) 12 (37.5%)
0 20 (62.5%)
34 (32–37) 35 (31–38)
1.9 (1.45–2.56) 1.9 (1.3–3.5)
11 (10–25) 6.5 (4–25)
spected group (n= 36) Control group (n= 32) P-value
Range Median Range
12–12 3 3.0–4.0 0.001
97–113 12.6 11–21 0.001
35.2–43.3 8.5 3.6–16.8 0.001
26.4–42.7 12.0 11.3–15.0 0.001
s neonates.









Table 4 Comparison of the AUC of CRP, IL-1, IL-6 and TNF in diagnosing sepsis with the sensitivity and speciﬁcity at their
optimum cutoff level.
Variable Cutoﬀ Sensitivity Speciﬁcity AUC SE 95% CI
CRP (mg/l) >12 91.7 100 0.978 0.0110 0.932–0.996
IL-6 (pg/ml) >16.8 100 47.06 0.686 0.0494 0.593–0.769
IL-1 (pg/ml) >15.04 100 47.06 0.642 0.0526 0.547–0.728
TNF-a (ng/ml) >113.28 83.33 100 0.967 0.0145 0.916–0.991
Figure 1 ROC curves of the AUC of CRP, IL-1, IL-6 and TNF
in diagnosing sepsis.
94 M.M. El-Sonbaty et al.tests. We have also estimated TNF-a, CRP, IL-6 and IL-1 in
the serum of the infected, clinically suspected sepsis and con-
trol neonates within 6 h of admission and before administra-
tion of antibiotics.
We demonstrated that septic neonates and neonates with
clinically suspected sepsis had signiﬁcantly elevated levels of
CRP. This was in line with the previous studies,3,11 and this
means that this parameter can differentiate healthy infants
from those with proven or suspected sepsis.
In addition, CRP was signiﬁcantly higher in septic group
when compared to neonates with suspected sepsis. This means
that this parameter was affected in suspected sepsis group and
differentiates them from healthy neonates and progressively
increases through the course of illness reaching signiﬁcantly
higher levels when sepsis is proven. Our data conﬁrmed the
previous reports on the advantage of repeated CRP measure-
ment as a diagnostic tool in neonatal sepsis.5,12 One study
looked at whether the time from onset of fever at which
CRP was measured affected its sensitivity or speciﬁcity. They
found no signiﬁcant difference in sensitivity or speciﬁcity
between CRP values collected before or after 12 h from the
onset of fever.13 However, some studies reported that the opti-
mum sensitivity and speciﬁcity for CRP were obtained during
the window of 24–48 h after the onset of symptoms.14 Some
studies also suggested that serial measurements of CRP over
a period of 2–3 days after onset clinical symptom, using vary-
ing cutoff values, improved the diagnostic performance of
CRP.15,16 However, another study indicated that measuring
CRP levels is not efﬁcient for the early diagnosis of infections
in infants.17 There are several studies which have used different
cutoff values for CRP ranging from 4.8 to 70 mg/l and have
reported that the sensitivity of CRP for identifying neonatal
infection ranges from 63% to 95%, and speciﬁcity ranges from
40% to 97%.18,19 In our study, CRP P12 mg/l was found to
be the most appropriate cutoff value by using ROC curves.
However, low test sensitivity and low negative predictivevalues for CRP in many studies have led them to think that
this test alone will not be sufﬁcient in the early diagnosis of
neonatal sepsis.20 From the available study, there seems to
be appropriate recommendation for the use of CRP in sepsis
patients. High CRP does suggest the presence of neonatal sep-
sis but must be used together with other markers to inform
clinical decision-making on a case-by-case basis.
In our study, we reported increased levels of TNF-a in both
culture proven sepsis group and clinically suspected sepsis
group compared to control group. Levels of TNF-a were also
higher in septic group when compared to neonates with
suspected sepsis. This also means that this parameter progres-
sively increases through the course of illness reaching signiﬁ-
cantly higher levels when sepsis is proven. However,
publishing data regarding TNF levels in neonatal sepsis is also
divergent. Some studies reported signiﬁcant increase of this
inﬂammatory mediator3,7 while others demonstrated compara-
ble or even lower levels in infected newborns compared to
healthy newborns.21,22 Prashant et al. reported increase in
TNF levels in infected and clinically suspected sepsis neonates
compared to healthy subjects although levels in infected and
clinically suspected sepsis neonates were comparable.7 We
reported high sensitivity (83.33%) and high speciﬁcity
(100%) of TNF in diagnosis of early stages of neonatal sepsis
at concentration >113.28 ng/ml. However, publishing studies
reported that the sensitivity of TNF ranged from 20.8% to
100% and speciﬁcity ranged from 43.1% to 100%.23
IL-6 is an important cytokine of the early response to infec-
tion. Previous studies have shown IL-6 to be a useful marker of
early infection in the newborn.3,24 In our study, the serum IL-6
levels were signiﬁcantly increased in newborns with sepsis com-
pared with control and were comparable between septic group
and suspected group. Kantar et al. showed that septic preterm
newborns had signiﬁcantly elevated IL-6 levels at the onset of
sepsis as compared to the recovery period and the controls.24
This supports ﬁndings reported by Magudumana et al. who
mentioned that there is no beneﬁt in serial determination of
IL-6 in the diagnosis of neonatal sepsis.25 Our results showed
that IL-6 shows 100% sensitivity and low speciﬁcity at
16.8 pg/ml cutoff value. A value of 10 mg/l is the most com-
monly used cutoff in most published studies.20 The cutoff val-
ues obtained by other investigators who measured IL-6 in
neonatal sepsis ranged between 3.6 and 500 pg/ml with mean
cutoff value = 76.49 pg/ml and median 30 pg/ml. The mean
sensitivity was 77.87% and speciﬁcity was 78.61%, at
76.49 pg/ml cutoff value.14 Although IL-6 is considered one
of early markers in neonatal sepsis, some factors do affect its
sensitivity and speciﬁcity to be widely used in neonatal
diagnosis.26 Its concentration increases sharply after exposure
to bacterial infection and it even precedes the increase in CRP
but it has a very short half-life, and its concentration falls
Biomarkers in diagnosis of early stages of neonatal sepsis 95dramatically with treatment and becomes undetectable within
24 h. In addition, it was reported that level of IL-6 shows nat-
ural ﬂuctuations immediately after the postnatal period and its
serum level is affected by gestational age and perinatal compli-
cations other than infection.26,27
In the other side, IL-1 levels were higher in proven infected
neonates and suspected sepsis group compared to control sub-
jects and its levels also showed signiﬁcant increase in suspected
sepsis group compared to proven infected neonates. In the cur-
rent study, IL-1 shows 100% sensitivity and low speciﬁcity at
15 pg/ml cutoff value. Results of different published studies
regarding this cytokine are contradictory. Santa et al. reported
that IL-1 showed increase in neonatal sepsis and its detection
sensitivity and speciﬁcity were 60% and 87% respectively.28
Kurt et al. reported that IL-1 levels in culture positive neonatal
sepsis at time of diagnosis were signiﬁcantly higher compared
to healthy subjects and after seven days of treatment.3 Ucar
et al. reported no increase in IL-1 in septic neonates compared
with healthy neonates. They explained this ﬁnding that the
monocytes of newborn infants may be unable to secrete ade-
quate IL-1.29 However, the previous ﬁnding is supported by
ﬁnding reported in a study done by Atici et al. who reported
that IL-1 levels were found to be lower in neonates with sepsis
than in healthy controls.30
However, reports in the literature on the use of CRP, TNF,
IL-6 and IL-1 as early markers of neonatal sepsis are contra-
dictory. Variations in study design, deﬁnition of neonatal sep-
sis, sample size, postnatal age, gestational age, risk factors,
inclusion criteria of patients, cutoff points of the markers, test
methodology, data analysis and reporting of results lead to dif-
ﬁculties in comparing studies.14,28,30,31 Thus, it is often difﬁcult
to formulate a deﬁnitive opinion on the clinical usefulness of
infection markers from the published reports.
Our study conﬁrmed previous ﬁndings that neonates with
bacterial sepsis have reduced platelet count and high I/T
ratio.9,10,29 TLC was comparable between studied groups
and this is in agreement with Ucar et al.29 In our study, I/T
ratio, was comparable between septic neonates and neonates
with clinically suspected sepsis, which means that abnormal
I/T ratio may occur earlier in cases with suspected sepsis and
reach levels comparable to those with proven sepsis. This con-
ﬁrmed the previous report of I/T ratio >0.2 as a useful marker
of infection.32 However, hematological parameters have shown
signiﬁcant heterogeneity among many studies. Da Silva et al.
reported that the possible sources of heterogeneity were gesta-
tional age of subjects, methodological quality, different refer-
ence values, different cutoff values and analysis of test
results by different laboratory observers.33
While evaluating the ﬁndings obtained from this study,
methodological limitations such as the small sample size and
the absence of follow-up for septic and clinically suspected sep-
tic neonates must be taken into account. However, ﬁndings
that were obtained from this study were strengthened by the
following factors: the presence of positive blood cultures in
all of the septic neonates; taking newborns at risk of neonatal
sepsis development and taking healthy newborns as control
group; the exclusion of neonates who were either delivered
by a mother that was using antibiotics or had used antibiotics
before.
At the end, our data analysis demonstrated that AUC of
TNF and CRP in the diagnosis of sepsis were superior to
determinations of IL-1 and IL-6. From our data analysisand based on our ﬁnancial backgrounds, we can conclude that
abnormal of CRP levels together with I/T ratio above 0.2 with
or without elevated IL-1, IL-6 or TNF can be used as early
markers of sepsis in neonates who are clinically suspicious
and could be used as an indication of starting antibiotic ther-
apy, in spite of negative or unavailable cultures at our NICU.
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